February 25, 2016 – European Medicines Agency (EMA) warns that over 100 cases of diabetic ketoacidosis have been linked to SGLT2 inhibitors in Europe.
2016 – European Medicines Agency warning
Announcement Date: February 25, 2016
February 25, 2016 – European Medicines Agency (EMA) warns that over 100 cases of diabetic ketoacidosis have been linked to SGLT2 inhibitors in Europe.